GetTopicDetailResponse(id=4a76919411b, topicName=諾誠健華, introduction=諾誠健華, content=null, image=null, comments=2, allHits=1785, url=https://h5.medsci.cn/topic?id=91941, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=89675, tagList=[TagDto(tagId=89675, tagName=諾誠健華)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=897029, encodeId=93b989e029d6, content=<a href='/topic/show?id=bf6758e90bf' target=_blank style='color:#2F92EE;'>#施一公#</a>創(chuàng)立的<a href='/topic/show?id=4a76919411b' target=_blank style='color:#2F92EE;'>#諾誠健華#</a>, objectTitle=今日，施一公創(chuàng)立的諾誠健華遞交港股上市申請, objectType=article, longId=181491, objectId=8dff18149194, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201910/20191017214151351.jpg, objectUrl=/article/show_article.do?id=8dff18149194, replyNumber=0, likeNumber=166, createdTime=2020-11-05, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8dff18149194, moduleTitle=今日，施一公創(chuàng)立的諾誠健華遞交港股上市申請, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8dff18149194)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=897028, encodeId=fb7f89e02822, content=<a href='/topic/show?id=4a76919411b' target=_blank style='color:#2F92EE;'>#諾誠健華#</a>是著名科學(xué)家<a href='/topic/show?id=bf6758e90bf' target=_blank style='color:#2F92EE;'>#施一公#</a>創(chuàng)立，同期的美國科學(xué)院院士<a href='/topic/show?id=a16768316c5' target=_blank style='color:#2F92EE;'>#王曉東#</a>創(chuàng)立了<a href='/topic/show?id=ac55e188816' target=_blank style='color:#2F92EE;'>#百濟(jì)神州#</a>，可惜<a href='/topic/show?id=4187101280e9' target=_blank style='color:#2F92EE;'>#饒毅#</a>沒有創(chuàng)立公司?，F(xiàn)在百濟(jì)已經(jīng)是巨頭，諾城健華上升很快，<a href='/topic/show?id=f67910401150' target=_blank style='color:#2F92EE;'>#奧布替尼#</a>很厲害！, objectTitle=諾誠健華奧布替尼獲美國FDA批準(zhǔn)開展治療多發(fā)性硬化癥臨床II期研究, objectType=article, longId=202938, objectId=6e7f20293886, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20201019/143455a04a6645338612b98e5e30a5e1.jpg, objectUrl=/article/show_article.do?id=6e7f20293886, replyNumber=0, likeNumber=227, createdTime=2020-11-05, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e7f20293886, moduleTitle=諾誠健華奧布替尼獲美國FDA批準(zhǔn)開展治療多發(fā)性硬化癥臨床II期研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6e7f20293886)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
